HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Paul Simon Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gross, C. Articles by Brücke, P. Search for Related Content PubMed PubMed Citation Articles by Gross, C. Articles by Brücke, P.

Ann Thorac Surg 1996;61:1759-1763
© 1996 The Society of Thoracic Surgeons

---

Original Article: Cardiovascular

Autologous Tissue Cardiac Valve for Aortic Valve Replacement: Technical Aspects and Early Results

Departments of Surgery I and Cardiology, General Hospital, Linz, Austria

Accepted for publication February 7, 1996.

Background. The known complications of heterograft bioprostheses and homograft valves have renewed the interest in the use of autologous material. A new technique to construct a tissue prosthesis for aortic valve replacement using the patient's pericardium harvested at the time of operation was developed. The glutaraldehyde-tanned pericardium is mounted on a stent requiring no suturing. Intraoperative testing assures adequate valve function.

Methods. The autologous tissue cardiac valve was implanted in 50 patients in the aortic position between March 1994 and May 1995. Echocardiograms were performed in all patients before hospital discharge, at 3 months (41 patients), and at the end of first postoperative year (12 patients). The mean age was 69.8 ± 5 years (range, 58 to 82 years). Eighty-four percent of patients presented with aortic stenosis and 16% had a combined lesion. Additional cardiac procedures were performed in 21 patients.

Results. Aortic cross-clamp time was 72 ± 19 minutes, and bypass time was 97 ± 28 minutes. There were three in-hospital deaths, and 2 patients died within the first postoperative year. Predischarge echocardiography demonstrated excellent hemodynamics, with a mean gradient of 20 ± 8 mm Hg and no or trivial aortic insufficiency in 45 patients. One patient had moderate aortic insufficiency. At first follow-up 36 patients (90%) were in New York Heart Association class I and 4 patients were in class II. Echocardiography showed no evidence of valve failure or degeneration (mean gradient, 17 ± 5 mm Hg; aortic insufficiency = grade 0 [trivial] in 35 patients, grade II in 3 patients, and grade III in 1 patient). Similarly, no degeneration or valve failure with increasing aortic insufficiency was seen in the patients studied at the end of the first postoperative year.

Conclusions. These results demonstrate that an autologous tissue cardiac valve can be manufactured in the operating room without significant additional operating time. Intraoperative testing minimizes the risk of primary failure with aortic insufficiency. Short-term results are encouraging, with good hemodynamic performance of the valve and no signs of degeneration. However, long-term durability needs to be demonstrated.

This article has been cited by other articles:

				M. Doss, R. Moid, J. P. Wood, A. Miskovic, S. Martens, and A. Moritz Pericardial Patch Augmentation for Reconstruction of Incompetent Bicuspid Aortic Valves Ann. Thorac. Surg., July 1, 2005; 80(1): 304 - 307. [Abstract] [Full Text] [PDF]

				C. Gross, P. Simon, M. Grabenwoger, R. Mair, K. Sihorsch, A. Kypta, M. Grimm, and P. Brucke Midterm results after aortic valve replacement with the autologous tissue cardiac valve Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 533 - 539. [Abstract] [Full Text] [PDF]